Ads
related to: keytruda cost- Treatment Information
Learn More About What To Expect
When Taking ADSTILADRIN®.
- Support & Resources
View Patient Assistance, Coverage
Support, & Other Valuable Resources
- Learn About ADSTILADRIN®
Discover Important Product
And Treatment Information.
- What Is ADSTILADRIN®?
Learn About Treatment With
ADSTILADRIN® And How It Works.
- Treatment Information
Search results
Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot
Reuters via Yahoo News· 1 year agoU.S. drugmaker Merck & Co hopes to patent a new formulation of its $20 billion cancer immunotherapy...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 3 weeks agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Merck Stock Has Been A Laggard For Seven Months. Is It Staging A Comeback?
Investor's Business Daily· 5 months agoMerck stock is shrugging off seven months of underperformance, shooting more than 7% higher in the...
Merck profit tops Wall Street view on strong Keytruda sales
Reuters via Yahoo Finance· 2 years ago(Reuters) -Merck & Co on Thursday reported higher-than-expected second-quarter earnings and revenue...
Merck posts better-than-expected results on Keytruda sales jump
Reuters via AOL· 4 months ago(Reuters) -Merck & Co reported better-than-expected fourth-quarter results on Thursday on strong...
Merck Scores Major Drug Approval, Easing Pain From Keytruda Patent Expiration
Barrons.com· 2 months agoMerck secured Food and Drug Administration approval for a drug widely expected to be an era-defining...
Pharma CEOs, pressed by Senate panel, refuse to commit to price cuts
BioPharma Dive via Yahoo Finance· 4 months agoThe CEOs of three major drugmakers defended the prices they charge U.S. patients in a Senate...
Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
The Wall Street Journal· 1 month agoShares of U.S. drugmaker Merck are up nearly 4% in recent trading after the company said its...
Merck scraps third prostate cancer study as Keytruda therapy disappoints
Reuters via Yahoo News· 1 year agoMerck & Co on Tuesday scrapped a late-stage trial of a combination therapy with its cancer drug...
Merck (MRK) Beats on Q3 Earnings & Revenues, Ups 2022 View
Zacks via Yahoo Finance· 2 years agoMerck & Co., Inc. MRK reported third-quarter 2022 adjusted earnings of $1.85 per share, beating the...
Ads
related to: keytruda cost